Retinal breaks due to intravitreal ocriplasmin

Ocriplasmin represents a new treatment option for numerous vitreoretinopathies involving an abnormal vitreomacular interface. While the drug may circumvent the traditional risks of surgical treatment, pharmacologic vitreolysis is not devoid of risk itself. This report presents two cases, one of vitr...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Ruwan A, Moshfeghi, Darius M, Leng, Theodore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154885/
https://www.ncbi.nlm.nih.gov/pubmed/25210426
http://dx.doi.org/10.2147/OPTH.S68037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154885/
https://www.ncbi.nlm.nih.gov/pubmed/25210426
http://dx.doi.org/10.2147/OPTH.S68037

Ejemplares similares